TB vaccine is better inhaledMarch 13th, 2008 - 2:05 pm ICT by admin
Washington, March 13 (IANS) An aerosol version of the common TB vaccine offers enhanced protection against the disease than a comparable dose of the injected vaccine, a new study has found. The aerosol vaccine, being developed under a collaboration between Harvard University and Medicine in Need (MEND), offers hope to millions of afflicted people with a low-cost, needle-free treatment that is also highly stable at room temperature.
The latest issue of the Proceedings of the National Academy of Sciences carries a report on the new vaccine.
Administered to 100 million infants annually, the current Bacillus Calmette-Gu
Tags: 100 million, academy of sciences, aerosol, alternative treatments, bacillus, barry r bloom, bcg vaccine, consistent protection, david edwards, developing countries, harvard university, immunization, national academy of sciences, proceedings of the national academy, proceedings of the national academy of sciences, public health experts, room temperature, tb vaccine, vaccines, variable degrees